LfC – Czerwieńsk

• 2000 – Acquisition of property in Czerwieńsk

The intensive development of LfC contributed to the search for a new, larger location for the company’s operations. In Czerwieńsk, on Składowa Street, a single-storey building with an area of over 1,200 m2, previously used as a railway canteen, was purchased. The location of the building and the layout of the rooms met the company’s needs at the time.

• 2003 – Opening of the LfC facility in Czerwieńsk

After three years of renovation and adaptation, the facility in Czerwieńsk has been commissioned. Production was the first to be launched here. Then the administration, quality control and sales departments were moved. A finished goods warehouse was also located here.

• 2005 – Launch of the clean zone

The implementation of a clean zone in the production process has resulted in an increase in the quality standards of LfC products; currently in accordance with the requirements of Regulation (EU) 2017/745 (MDR) and ISO 13485. The zone includes cleanliness class C and D rooms, where the final washing, disinfection and packaging of products takes place. Access to the zone is restricted to qualified LfC personnel, who operate according to strict, controlled procedures.

• 2011 – Implementation of 3D-Ti-EBM printing technology

LfC purchased and launched at its Czerwieńsk branch the most advanced high-vacuum titanium powder printing technology of that time, utilizing Electron Beam Melting (EBM). In the same year, a new design was developed, and production of the world’s first 3D-Ti implants began. It was a technological breakthrough—a milestone!

• 2015 – Expansion of the branch in Czerwieńsk

With the use of external funding (project no. RPLB.01.01.00-08-0004/16-00, RPO-Lubuskie 2020), the company has launched a new investment in Czerwieńsk. A Research and Development (R&D) Center for advanced prototyping and evaluation of innovative medical technologies for spinal surgery, covering an area of nearly 500 m², has been added.

• 2018 – Opening of the R&D Centre

The implementation of the new Centre into LfC’s operations was another significant achievement for the company’s growth. The Centre was equipped with advanced engineering software and modern research and measurement equipment necessary for effective prototyping and, above all, the production of custom-made medical devices (CMD) for the entire human skeletal system.

• 2025 – Next-generation 3D printing technology

In line with development trends and medical needs, LfC, with support from the KPO programme (KPOD.01.13-IW.01-0417/24), has purchased and is implementing a 3D-Ti printing system with a Q10plus device, a latest-generation solution, in its production process. This investment requires the reconstruction of premises and their adaptation to environmental requirements. Currently, titanium implants produced using 3D-Ti printing with the EBM method already constitute a large family, accounting for over 50% of LfC’s product portfolio.